NCT00472459 - Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 25, 2003

Primary Completion Date

September 23, 2004

Study Completion Date

July 14, 2006

Conditions

Actinic KeratosisWartsBasal Cell CarcinomaBowens DiseaseSquamous Cell Carcinoma

Interventions

PROCEDURE

Photodynamic therapy with Metvix 160 mg/g cream

Trial Locations (11)

Department of Dermatology, Roskilde Amysygehus, Roskilde

Department of Dermatology, St. Olavs Hospital, Trondheim

Department of Dermatology, Århus Amysygehus, Aarhus

Klinik für Dermatologie, Venerologie und Allergologie, Campus Charité Mitte, Berlin

Department of Dermatology, Karolinska University Hospital, Huddinge, Stockholm

Hautklinik Linden, Hanover

Department of Dermatology, Sahlgrenska University Hospital, Gothenburg

Department of Dermatology, Uppsala University Hospital, Uppsala

Department of Dermatology, Rikshospitalet, Oslo

Dermatology Department, Manchester Royal Infirmary, Manchester

Portsmouth Dermatology Centre, St Mary's Hospital, Portsmouth